These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 6957656

  • 1. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report.
    Tanaka T, Pellis NR, Kahan BD.
    J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656
    [Abstract] [Full Text] [Related]

  • 2. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens].
    Tanaka T, Yamagishi H, Inaba S, Kobayashi M, Kurioka H, Naito K, Hashimoto I.
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):282-94. PubMed ID: 6201713
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD, Tanaka T, Pellis NR.
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [Abstract] [Full Text] [Related]

  • 4. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K, Pellis NR, Kahan BD.
    Cancer Res; 1988 Jan 01; 48(1):101-8. PubMed ID: 3257158
    [Abstract] [Full Text] [Related]

  • 5. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
    Nomi S, Naito K, Kahan BD, Pellis NR.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6111-5. PubMed ID: 3779631
    [Abstract] [Full Text] [Related]

  • 6. Biochemical characterization of 1-butanol-extracted murine tumor-specific transplantation antigens.
    LeGrue SJ, Pellis NR, Riley LB, Kahan BD.
    Cancer Res; 1985 Jul 01; 45(7):3164-72. PubMed ID: 2408745
    [Abstract] [Full Text] [Related]

  • 7. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide.
    Nomi S, Pellis NR, Kahan BD.
    J Natl Cancer Inst; 1984 Oct 01; 73(4):943-50. PubMed ID: 6237215
    [Abstract] [Full Text] [Related]

  • 8. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice.
    Nomi S, Naito K, Kahan BD, Pellis NR.
    Cancer Res; 1986 Nov 01; 46(11):5606-10. PubMed ID: 2875791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
    Tsuchiya K, Yamagishi H, Hamada H, Komichi H, Oka T, Tanaka T, Inaba S.
    Nihon Geka Gakkai Zasshi; 1987 Jul 01; 88(7):826-31. PubMed ID: 2444868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
    LeGrue SJ, Simcik WJ, Frost P.
    Cancer Res; 1987 Aug 15; 47(16):4413-6. PubMed ID: 3607772
    [Abstract] [Full Text] [Related]

  • 14. [Induction of immunogenic variant of a murine fibrosarcoma].
    Kobayashi M, Yamagishi H, Nomi S, Ueda Y, Hayashi T, Oka T.
    Nihon Geka Gakkai Zasshi; 1992 Nov 15; 93(11):1372-7. PubMed ID: 1448043
    [Abstract] [Full Text] [Related]

  • 15. [The immunotherapeutic effect of partially purified tumor specific transplantation antigen against pulmonary metastasis].
    Inaba S, Tanaka T, Yamagishi H, Kobayashi M, Tsuchiya K, Oka T.
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec 20; 19(10):2273-8. PubMed ID: 6533208
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection.
    Pellis NR, Kahan BD.
    J Immunol; 1975 Dec 20; 115(6):1717-22. PubMed ID: 52676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.